Cape Town: The third phase trial of Sinovac, a covid vaccine for children, has been started in South Africa. Sinovac, a Chinese pharmaceutical company, has partnered with African company Pneumovax Group to launch the trial.
The third phase will test the safety, efficiency, and immunity of children between the ages of 6 months and 17 years, according to Sinovac.
The vaccine has been used in China since May after the inactivated Sinovac vaccine was shown to be effective in people between the ages of 3 and 17.
